AKT1 and myxoma: In the present study, stimulation with IL-6 + sIL-6R resulted in an increase in IL-6 mRNA, and pharmacological inhibitors against JAK/STAT3 and PI3L/Akt inhibited the IL-6 + sIL-6R-induced activation of IL-6 mRNA in the myxoma cells.